Sign In
Last checked at 31 Jul 2007 07:01
EpiStem Holdings plc31 July 2007 EPISTEM HOLDINGS PLC TRADING UPDATE - JULY 2007 The Board Of Directors of EpiStem Holdings Plc confirm that the results for theCompany for the year ended 30th June 2007 are in line with managementexpectations with a year on year revenue growth of approximately 50% beingachieved. Further details of the financial performance for the year will beannounced in October 2007 (to be confirmed). The Board of Directors is also pleased to announce the appointment of RogerLloyd as a non-executive Director of the Company. Dr Lloyd, aged 59, brings awealth of experience to EpiStem, having only recently stood down as ExecutiveDirector, Global Licensing at AstraZeneca plc. In this capacity, he headed upthe deal making team responsible for the acquisitions by AstraZeneca ofCambridge Antibody Technologies plc and KuDOS Pharmaceuticals Limited as well asother strategically important transactions. This information is provided by RNS The company news service from the London Stock Exchange
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Genedrive Regulatory News (GDR)
GDR Share
Price
GDR Share
News
GDR Share
Chat
GDR Share
Trades35
GDR
Live RNS
GDR Share
Charts
GDR Level 2
Console
GDR Live
Share Price
GDR Broker
Ratings
GDR Directors
Deals
GDR Financial
Diary
GDR
Fundamentals
GDR Short
Positions
GDR
Media
GDR Company
Research
GDR Company
Timeline
Genedrive Information
Share Price Information for Genedrive (GDR)
Share Price is delayed by 15 minutes
Get Live Data
1.30
0.00 (0.00%)
Bid:
1.25
Ask:
1.35
Spread:
0.10 (8.00%)
Market Cap:
£20.87m
Last checked at -
Intraday Genedrive Share Chart
Trading Update
| Date | Source | Headline | |
|---|---|---|---|
| 17th Mar 2009 | 5:08 pm | RNS | Additional Listing |
| 11th Mar 2009 | 7:04 am | RNS | Half Yearly Report |
| 2nd Mar 2009 | 7:00 am | RNS | Re Agreement |
| 24th Feb 2009 | 11:22 am | RNS | Notice of Results |
| 5th Dec 2008 | 7:30 am | RNS | Annual Report and Accounts |
| 28th Nov 2008 | 7:30 am | RNS | Change of Nomad and Adviser |
| 10th Nov 2008 | 7:30 am | RNS | Change of Nomad and Adviser |
| 13th Oct 2008 | 8:54 am | RNS | Issue of Equity & TVR |
| 8th Oct 2008 | 3:19 pm | RNS | Change of Adviser Name |
| 6th Oct 2008 | 7:00 am | RNS | Preliminary Results - October 2008 |
| 1st Sep 2008 | 7:30 am | RNS | EPISTEM AND ROTTAPHARM ANNOUN |
| 31st Jul 2008 | 11:06 am | RNS | Trading Update |
| 24th Jul 2008 | 8:54 am | RNS | EPISTEM ANNOUNCE COLLABORATIO |
| 23rd Jun 2008 | 7:00 am | RNS | MASCC Conference |
| 7th Apr 2008 | 7:01 am | RNS | Data to be Released at AACR |
| 1st Apr 2008 | 10:31 am | RNS | Epistem services for EBI |
| 5th Mar 2008 | 4:31 pm | RNS | Senior Management Appointment |
| 28th Feb 2008 | 7:30 am | RNS | Interim Results |
| 12th Feb 2008 | 11:57 am | RNS | Notice of Results |
| 30th Nov 2007 | 4:23 pm | RNS | Total Voting Rights |
| 28th Nov 2007 | 2:17 pm | RNS | AGM Statement |
| 20th Nov 2007 | 3:32 pm | RNS | Issue of Equity |
| 2nd Nov 2007 | 8:56 am | RNS | Notifiable Interest |
| 2nd Nov 2007 | 8:41 am | RNS | Notice of AGM |
| 23rd Oct 2007 | 10:15 am | RNS | Director/PDMR Shareholding |
| 10th Oct 2007 | 7:01 am | RNS | Preliminary Results |
| 20th Sep 2007 | 7:01 am | RNS | Research Update |
| 17th Aug 2007 | 9:57 am | RNS | AIM Rule 26 |
| 31st Jul 2007 | 7:01 am | RNS | Trading Update |
| 28th Jun 2007 | 2:16 pm | RNS | Directors Shareholdings |
| 22nd May 2007 | 7:30 am | RNS | Research Update |
| 4th Apr 2007 | 8:00 am | RNS | Admission to AIM |
Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.
To access our Live RNS you must confirm you are a private investor by using the button below.
Follow the stocks
